Results 1 to 10 of about 60,915 (280)
SERUM HSP 70 LEVELS OF CHRONIC HEPATITIS B PATIENTS ARE SUBSTANTIALLY CORRELATED WITH HBsAg [PDF]
Euromediterranean Biomedical Journal, 2020 Heat-shock protein 70 (HSP70) is a stress-induced protein that demonstrates the anti-apoptosis response that ensures the survival of cells. The aim of this study is to investigate the significant correlation of serum HSP70 levels in chronic hepatitis B ...
Awaz Saadi
doaj +1 more source
Zhongguo shuxue zazhi, 2023 Objective To investigate the characteristics of HBV serological markers of NAT reactive blood donors under different HBsAg status. Methods NAT reactive samples, with HBsAg-, HBsAg+ /retest - and HBsAg+ by single reagent were collected from September 2021
Dequn NI +7 more
doaj +1 more source
The role of Recombinant interleukin-2 in the treatment of patients with chronic hepatitis B.
Инфекция и иммунитет, 2023 Dysregulated immune response occurring in chronic hepatitis B prevents the virus elimination and contributes to progression of the infectious process.
Anastasiya F. Novikova +2 more
doaj +1 more source
Performance Evaluation of an Improved HBsAg Assay (HBsAg NEXT) for the Detection of HBsAg Levels
Journal of Laboratory Physicians, 2023 Abstract Objectives Detection of hepatitis B surface antigen (HBsAg) plays an important role in the screening and diagnosis of hepatitis B virus (HBV) infections. There is a need of highly sensitive assays with an improved lower limit of detection (LoD).
Ekta Gupta +6 more
openaire +2 more sources
Efficient conjugation of anti-HBsAg antibody to modified core-shell magnetic nanoparticles (Fe3O4@SiO2/NH2) [PDF]
BioImpacts, 2021 Introduction: Further development of magnetic-based detection techniques could be of significant use in increasing the sensitivity of detection and quantification of hepatitis B virus (HBV) infection.
Shahram Parvaneh +4 more
doaj +1 more source
How does the immunogenicity of hepatitis B vaccine change over the years in childhood?
Human Vaccines & Immunotherapeutics, 2021 Hepatitis B is the leading cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma worldwide. The incidence of HBV infection has significantly decreased with hepatitis B vaccination. Hepatitis B vaccine is administered to children at 0, 1 and
Gulsum Iclal Bayhan +3 more
doaj +1 more source
PreHevbrio: the first approved 3-antigen hepatitis B vaccine
Expert Review of Vaccines, 2023 Introduction Hepatitis B remains a major cause of death and morbidity worldwide. Universal childhood immunization programs have been very successful, but many adults remain unprotected or are not optimally protected.
Timo Vesikari +3 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2021 Recommendations promoted worldwide have suggested a period of protection lasting more than 20 years against hepatitis B (HB) following primary immunization. Starting in 1987, universal HB vaccinations were carried out in Long An County, Guangxi Province,
Zhigang Zheng +8 more
doaj +1 more source
Journal of Agriculture, Food and Environment, 2022 The study area (Sahel savannah zone of Nigeria) was delineated into five sampling districts, which were further delineated into three localities from where raw and processed sorghum based products were collected.
Garba MH
doaj +1 more source
IL-10 Promoter Polymorphism Distribution among HBsAg-Reactive and HBsAg-Nonreactive Blood Donors
Majalah Kedokteran Bandung, 2020 Hepatitis B surface antigen (HBsAg) serves as a serological marker for Hepatitis B virus (HBV) infection. People with HBV asymptomatic infection might readily donate blood due to the lack of clinical manifestations.
Rahmat Azhari Kemal +5 more
doaj +1 more source